Last reviewed · How we verify

NCT06010030

HD-tDCS for Phonological Impairment in Aphasia

Active, enrolled NA Last updated 13 March 2026
What this trial tests

NA trial testing Targeted Transcranial Direct Current Stimulation in Aphasia in 200 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
3 October 2023
Primary endpoint
1 January 2033
1 January 2033

Quick facts

Lead sponsorMedical College of Wisconsin
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment200
Start date3 October 2023
Primary completion1 January 2033
Estimated completion1 January 2033
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical College of Wisconsin

Who can join

Adults 18 to 85, any sex, with Aphasia or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Targeted Transcranial Direct Current Stimulation

Trials testing the same drug.

Other recruiting trials for Aphasia

Currently open trials in the same condition.

Other Medical College of Wisconsin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06010030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing